| |
Men (n = 3481)
|
Women (n = 4059)
|
|---|
| | |
n
|
ApoB, g/L
|
ApoA1, g/L
|
ApoB/ApoA1
| |
n
|
ApoB, g/L
|
ApoA1, g/L
|
ApoB/ApoA1
|
|---|
|
SF, μg/L
|
|
Q1
|
51.9 (37.8, 62.8)
|
872
|
0.82 (0.68, 1.00)
|
1.08 (0.93, 1.26)
|
0.75 (0.59, 0.94)
|
13.0 (7.4, 18.5)
|
1015
|
0.78 (0.65, 0.94)
|
1.10 (0.96, 1.27)
|
0.69 (0.56, 0.85)
|
|
Q2
|
95.5 (84.3, 106.8)
|
869
|
0.86 (0.71, 1.02)
|
1.09 (0.94, 1.27)
|
0.77 (0.62, 0.97)
|
35.5 (29.0, 43.2)
|
1015
|
0.84 (0.69, 1.01)*
|
1.11 (0.97, 1.28)
|
0.73 (0.58, 0.92)*
|
|
Q3
|
147.9 (132.6, 169.5)
|
870
|
0.90 (0.74, 1.09)*#
|
1.09 (0.93, 1.28)
|
0.82 (0.64, 1.03)*#
|
67.5 (58.6, 78.0)
|
1015
|
0.93 (0.76, 1.11)*#
|
1.13 (1.00, 1.31)*
|
0.79 (0.63, 0.98)*#
|
|
Q4
|
379.9 (253.2, 609.0)
|
870
|
0.95 (0.78, 1.13)*#†
|
1.05 (0.88, 1.25)*#†
|
0.92 (0.71, 1.14)*#†
|
140.2 (109.7, 203.3)
|
1014
|
0.99 (0.81, 1.20)*#†
|
1.13 (0.98, 1.31)
|
0.86 (0.69, 1.06)*#†
|
|
TRF, g/L
|
|
Q1
|
2.25 (2.10, 2.36)
|
831
|
0.83 (0.69, 0.99)
|
1.06 (0.91, 1.27)
|
0.76 (0.59, 0.95)
|
2.35 (2.18, 2.46)
|
957
|
0.88 (0.71, 1.05)
|
1.12 (0.97, 1.30)
|
0.76 (0.61, 0.97)
|
|
Q2
|
2.60 (2.52, 2.66)
|
857
|
0.87 (0.72, 1.04)*
|
1.08 (0.92, 1.28)
|
0.79 (0.63, 1.01)
|
2.71 (2.64, 2.78)
|
1029
|
0.88 (0.73, 1.06)
|
1.12 (0.97, 1.29)
|
0.78 (0.62, 0.95)
|
|
Q3
|
2.91 (2.82, 3.01)
|
977
|
0.89 (0.73, 1.07)*
|
1.08 (0.93, 1.25)
|
0.83 (0.64, 1.04)*
|
3.05 (2.95, 3.14)
|
1036
|
0.88 (0.72, 1.09)
|
1.12 (0.98, 1.30)
|
0.76 (0.61, 0.97)
|
|
Q4
|
3.35 (3.22, 3.60)
|
816
|
0.93 (0.77, 1.13)*#†
|
1.08 (0.92, 1.28)
|
0.86 (0.68, 1.10)*#†
|
3.56 (3.38, 3.85)
|
1037
|
0.87 (0.72, 1.08)
|
1.12 (0.99, 1.30)
|
0.76 (0.60, 0.95)
|
|
sTfR, mg/L
|
|
Q1
|
0.90 (0.80, 0.98)
|
835
|
0.86 (0.71, 1.05)
|
1.04 (0.90, 1.21)
|
0.82 (0.64, 1.05)
|
0.97 (0.86, 1.06)
|
989
|
0.87 (0.71, 1.05)
|
1.08 (0.95, 1.25)
|
0.78 (0.62, 0.98)
|
|
Q2
|
1.15 (1.10, 1.21)
|
839
|
0.86 (0.72, 1.03)
|
1.10 (0.94, 1.27)*
|
0.78 (0.61, 0.97)*
|
1.19 (1.26, 1.31)
|
926
|
0.87 (0.72, 1.05)
|
1.12 (0.98, 1.30)*
|
0.75 (0.60, 0.93)
|
|
Q3
|
1.39 (1.32, 1.46)
|
905
|
0.88 (0.73, 1.07)
|
1.08 (0.93, 1.28)*
|
0.80 (0.64, 1.03)
|
1.52 (1.44, 1.62)
|
1156
|
0.91 (0.73, 1.10)*
|
1.14 (0.99, 1.31)*
|
0.78 (0.61, 0.98)
|
|
Q4
|
1.82 (1.67, 2.12)
|
902
|
0.92 (0.74, 1.09)*#
|
1.08 (0.92, 1.29)*
|
0.83 (0.64, 1.05)#
|
2.09 (1.88, 2.51)
|
988
|
0.87 (0.72, 1.06)
|
1.14 (0.98, 1.33)*
|
0.74 (0.60, 0.93)
|
|
Hb, g/L
|
|
Q1
|
134.0 (126.0, 139.0)
|
871
|
0.82 (0.68, 0.99)
|
1.08 (0.94, 1.27)
|
0.75 (0.58, 0.94)
|
116.0 (109.0, 120.0)
|
1056
|
0.83 (0.68, 1.00)
|
1.13 (0.96, 1.30)
|
0.72 (0.58, 0.90)
|
|
Q2
|
148.0 (145.0, 150.3)
|
906
|
0.87 (0.70, 1.04)*
|
1.08 (0.92, 1.28)
|
0.79 (0.61, 1.01)*
|
128.0 (126.0, 130.0)
|
1089
|
0.86 (0.71, 1.03)*
|
1.11 (0.98, 1.30)
|
0.76 (0.60, 0.93)*
|
|
Q3
|
157.0 (155.0, 160.0)
|
869
|
0.92 (0.76, 1.07)*#
|
1.07 (0.92, 1.25)
|
0.84 (0.66, 1.07)*#
|
136.0 (134.0, 138.0)
|
929
|
0.90 (0.73, 1.10)*#
|
1.12 (0.99, 1.32)
|
0.78 (0.62, 0.99)*#
|
|
Q4
|
165.0 (169.0, 177.0)
|
835
|
0.92 (0.76, 1.13)*#
|
1.05 (0.91, 1.26)
|
0.86 (0.68, 1.08)*#
|
147.0 (143.0, 155.0)
|
985
|
0.93 (0.76, 1.13)*#
|
1.12 (0.97, 1.28)
|
0.81 (0.64, 1.01)*
|
- Data are presented as medians (interquartile range)
- ApoB apolipoprotein B, ApoA1 apolipoprotein A1, SF serum ferritin, TRF transferrin, sTfR soluble transferrin receptor, Hb hemoglobin, Q quartile
- *P < 0.05 compared with the reference Q1; #P < 0.05 compared with the reference Q2; †P < 0.05 compared with the reference Q3
